NRR Diagnostic: The 90-Day Checklist for Retention-Led Growth

NRR is the most important commercial metric you have, and it's the one most companies measure too late. You see it in the board deck. You don't see the five structural conditions that determined it six months earlier. A 90-day NRR diagnostic is not about explaining last quarter's number. It's about finding the conditions that are setting next year's number right now, before they're locked in.

What It Actually Costs

The P&L math on NRR is unambiguous. A $60M annual recurring revenue (ARR) company with 95% NRR is losing $3M per year from its existing base before it adds a single new customer. At 115% NRR, that same base contributes $9M in expansion revenue. The delta between 95% and 115% NRR is $12M in annual revenue from the same customer count. That's not a sales problem. It's a commercial architecture problem.

The compounding effect is even starker. Two companies at $60M ARR, one at 95% NRR and one at 115% NRR, reach fundamentally different revenue bases in year three even if they add new logos at identical rates. The 115% company's base grows without additional sales cost. The 95% company's sales team is running to stand still.

The Approach

Area 1: Gross churn measurement

• Do you calculate gross churn separately from net churn in every reporting period?
• Is gross churn segmented by customer cohort, segment, and acquisition vintage?
• Do you know whether gross churn is concentrated in the first 12 months, the 24-month mark, or later?
• Is there a named commercial owner of gross churn, not just a customer success (CS) team metric?

Area 2: Renewal pricing mechanism

• Do you have a documented renewal pricing policy that includes a price increase component?
• What percentage of your renewals included a price increase in the last 12 months?
• Is renewal pricing approached from a fresh value basis or from the prior year's contracted structure?
• Are your AEs involved in renewal pricing decisions or is it entirely owned by CS?

Area 3: Expansion revenue architecture

• Is expansion revenue driven by a defined CS-led motion or by customer initiative?
• Do you have a documented upsell and cross-sell playbook with specific trigger criteria?
• What percentage of your accounts expanded in the last 12 months?
• What is your average expansion ARR per customer, and has it grown year over year?

Area 4: Ideal customer profile (ICP) fit and growth potential

• Have you segmented your customer base by ICP fit and correlated it with NRR?
• Does your strongest NRR cohort match your current new business ICP targeting?
• Are there specific verticals or company sizes in your base that consistently over-expand?
• Is sales incentivized to close deals with high lifetime expansion potential, or just high initial annual contract value (ACV)?

Area 5: Commercial handoff quality

• Is there a documented handoff process from AE to CS that includes deal economics and buyer context?
• Do CSMs know the original discount rate and deal structure for accounts they manage?
• Is there a defined point at which a struggling account triggers a commercial review, not just a quarterly business review (QBR)?
• Do your CSMs have authority to execute commercial actions (upsell, renewal negotiation) or do they always need AE involvement?

Area 6: Data visibility

• Can your CS team see product usage data in their standard workflow without an engineering pull?
• Is NRR tracked at the individual customer success manager (CSM) level as a performance metric?
• Do you have a real-time customer health score that incorporates usage, support, and commercial signals?
• How long does it take your team to produce a current NRR calculation broken out by segment?

Where This Breaks

A $60M ARR enterprise software company had NRR of 97%. Management attributed it to "market conditions." The NRR diagnostic found a different story.

Expansion revenue was entirely driven by customer-initiated requests. No proactive upsell motion existed. The CS team managed accounts reactively. The four verticals that made up 60% of ARR had expansion rates of under 2% annually, while two verticals making up 15% of ARR had expansion rates of 18%. Sales was targeting the low-expansion verticals because that's where the pipeline was.

Before: $60M ARR, 97% NRR, no proactive expansion motion, sales focused on low-expansion verticals. After (NRR diagnostic and 90-day remediation): Proactive upsell playbook implemented, sales ICP revised to prioritize high-expansion verticals, NRR reached 108% in 18 months, $6.6M in expansion ARR from existing base versus $1.8M the prior year.

Next Actions This Week

Pick one checklist area and answer every question in it today using your CRM and product data. If you can't answer more than two questions in any area without a custom data pull, that data gap is itself a finding.

Your NRR for the next 12 months is being determined right now by conditions you can still influence.

Run the FintastIQ NRR Diagnostic to get a structured view of your expansion and retention gaps.

Related reading: First Principles: Net Revenue Retention (NRR) for PE-Backed (private equity) Companies and How to Measure the ROI of Net Revenue Retention (NRR).